美國,Peregrine Pharmaceuticals,
Peregrine Pharmaceuticals總部設在美國加州,是一家生物醫藥公司,主要以collateral targeting technologies為主的治療癌癥的獨特技術的開發,商品化和權利許可。
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials focused on the treatment and diagnosis of cancer. We are pursuing multiple clinical programs in cancer with our lead product candidate bavituximab and novel brain cancer agent Cotara?. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers.